Register Login
Register to leave comments
  • News bot Aug. 18, 2026, 8:54 p.m.

    🔍 Robb Gary Charles (Executive)

    Company: CORCEPT THERAPEUTICS INC (CORT)

    Report Date: 2026-08-17

    Transaction Summary:

    • Total transactions: 4
    • Derivative instruments: 0
    • Holdings reported: 2
    • Total shares sold: 10,125
    • Total shares held: 31,142

    Detailed Transactions and Holdings:

    • Sold 125 shares of Common Stock (Direct)
      Date: 2026-08-17 | Code: G | equity_swap_involved: false | shares_owned_after: 13,426.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 10,000 shares of Common Stock at $116.2572 per share (Direct)
      Date: 2026-08-17 | Code: S | equity_swap_involved: false | shares_owned_after: 39,716.00 | transaction_form_type: 4 | Footnotes: F2, F3
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-08-17 | Code: H | nature_of_ownership: Custodial Account for Child | shares_owned_after: 15,571.00 | Footnotes: F4
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-08-17 | Code: H | nature_of_ownership: Custodial Account for Child | shares_owned_after: 15,571.00 | Footnotes: F5

    Footnotes:

    • F1: Includes 251 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 499 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 776 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.
    • F2: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $116.00 to $116.54 per share. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
    • F3: These shares are held by Gary Charles Robb TTE Robb Revocable Trust of which the Reporting Person is trustee.
    • F4: These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian.
    • F5: These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian.
    • REMARKS: The power of attorney under which this form was signed is on file with the Commission.

Search

News categories